Decision-ready evidence, accelerated.
We generate comparative evidence for market access.
We combine deep methodological expertise with purpose-built workflows to generate the comparative evidence your asset needs, in weeks instead of months.
Your drug has never been compared directly against the alternative.
Your pivotal evidence comes from a single-arm trial. Or you have randomised data but not against standard of care or the drug your asset is competing with.
HTA bodies, payers, and clinical teams all want the same answer: how does your drug compare to what patients already receive?
That answer must come from evidence outside your trial. And it has to hold up to external scrutiny.
Evidax in numbers
- 20 days
- Integrated Evidence Plan
- 14 days
- Systematic review and meta-analysis
- 10 days
- Indirect treatment comparison
- 15 years
- Leading clinical research programmes
What we do
When your asset needs comparative data from outside a pivotal trial, we do two things exceptionally well: evidence strategy and evidence generation.
Evidence strategy
Evidence gap analysis
We map exactly what evidence you have, what is missing, and what each key stakeholder needs to see.
Integrated evidence plans
We build one multi-purpose plan that serves regulators, HTA bodies, payers, and clinicians simultaneously.
Evidence generation
Systematic reviews and meta-analyses
We synthesise every piece of published evidence on your question, and deliver the full pooled analysis, aligned with PRISMA and Cochrane guidance.
Comparative evidence
We compare your drug against the alternative using summary results published from other trials or patient-level data from real-world data sources.
Evidax is built differently
Working with a conventional firm
Working with a conventional firm usually goes like this: You are charged separately for every piece of work. Evidence generation takes several months. And the analysis is run by someone who has never developed an asset of their own.
Working with Evidax
Evidax is relentlessly outcome-driven; we agree the outcome first and work with you until it is delivered, with no extra charges along the way. We generate evidence in weeks rather than months, using workflows we built ourselves. And every analysis is run by a senior methodologist who has led major research programmes and developed their own asset.
Your streamlined evidence plan, live and in one place
The Evidax Workspace keeps your whole team aligned as the plan evolves and new evidence is generated.
Leadership team
Dr Sam Orange
Founder & Chief Scientific Officer
Professor Ian Hickson
Senior Scientific Adviser: Drug discovery
Dr Tom Maden-Wilkinson
Senior Scientific Advisor: Biotech strategy
Professor James Wason
Senior Scientific Advisor: Biostatistics
Ben Porter
Senior Scientific Advisor: RWE and evidence synthesis